II. Oncogenes and growth factors
The androgen receptor: Functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines

https://doi.org/10.1016/0960-0760(90)90429-OGet rights and content

Abstract

The growth of the majority of prostate tumors is androgen-dependent, for which the presence of a functional androgen receptor is a prerequisite. Tumor growth can be inhibited by blockade of androgen receptor action. However, this inhibition is transient. To study the role of the androgen receptor in androgen-dependent and androgen-independent prostate tumor cell growth, androgen receptor mRNA expression was monitored in six different human prostate tumor cell lines and tumors, which were grown either in vitro or by transplantation on (male) nude mice. Androgen receptor mRNA was clearly detectable in three androgen-dependent (sensitive) tumors and absent or low in three androgen-independent tumors. Growth of the LNCaP prostate tumor cell line can be stimulated both by androgens and by fetal calf serum. In the former situation androgen receptor mRNA expression is downregulated, whereas in the latter no effect on androgen receptor mRNA levels can be demonstrated. Sequence analysis showed that the androgen receptor gene from LNCaP cells contains a point mutation in the region encoding the steroid-binding domain, which confers an ACT coVon encoding a threonine residue to GCT, encoding alanine.

References (34)

  • C. Chang et al.

    Molecular cloning of human and rat complementary DNA encoding androgen receptors

    Science

    (1988)
  • D.B. Lubahn et al.

    Cloning of human androgen receptor complementary DNA and localization of the X chromosome

    Science

    (1988)
  • C. Chang et al.

    Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors

  • D.B. Lubahn et al.

    The human androgen receptor: complementary deoxyribonucleotide cloning, sequence analysis and gene expression in prostate

    Mol. Endocrinol.

    (1988)
  • W.D. Tilley et al.

    Characterization and expression of cDNA encoding the human androgen receptor

  • G.R. Cunha et al.

    The endocrinology and developmental biology of the prostate

    Endocr. Rev.

    (1987)
  • J.A. Ruizeveld de Winter et al.

    Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry

    J. Pathol.

    (1990)
  • Cited by (59)

    • Reproductive and nonreproductive actions of testosterone

      2018, Encyclopedia of Endocrine Diseases
    • Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells

      2013, Urologic Oncology: Seminars and Original Investigations
      Citation Excerpt :

      For experiments, LNCaP cells were seeded in 6-well plates or T-75 flasks at 1 × 105 cells/ml, with or without brefeldin A (BFA) (Epicentre Technologies, Madison, WI). In some experiments, cells were cultured in medium with 5% charcoal-stripped FBS (CS-FBS) containing a negligible amount of steroids [12], and DHT (5α-dihydrotestosterone) was also used as an androgenic regulator. Cell number/viability was determined by trypan blue exclusion method.

    • Progression of prostate cancer: Multiple pathways to androgen independence

      2009, Cancer Letters
      Citation Excerpt :

      These findings suggest that the variability in AR content increases with the progression of the disease and might in part account for hormone resistance [74–77]. Absence of AR mRNA and protein expression has been shown in the androgen-independent human prostate tumor cell lines DU145 and PC3 [78,79]. The loss of AR expression in these androgen-independent cells appears to occur at the transcriptional level through CpG methylation of the AR promoter and histone deacetylation, instead of at the genomic level through either deletion or mutation [6,80–83].

    View all citing articles on Scopus
    View full text